US$ 28.12
glp 1 parkinson's Repurposing GLP-1 Receptor Agonists for Disease: Current Evidence and Future Opportunities | Pharmaceutical Medicine glp 1 and parkinson's disease
Description
Evidence that intestinal glucagonlike peptide1 plays a physiological role in satiety

This is likely due to their role in dampening the brains reward circuits

It reduces appetite and how much you eat
On Oprahs podcast, she even shared how shes got knees like Megan now

doi: 10.2337/dc13-2759

Want To Learn More
